Mutation of putative N-Linked glycosylation sites in japanese encephalitis virus premembrane and envelope proteins enhances humoral immunity in BALB/C mice after DNA vaccination

Virology Journal

Volumn 8, Issue , 2011, Pages

  Zhang, Yu ^a   Chen, Puyan ^a   Cao, Ruibing ^a   Gu, Jinyan ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; JAPANESE ENCEPHALITIS VACCINE; PREMEMBRANE PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; MEMBRANE PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA IMMUNIZATION; FEMALE; GLYCOSYLATION; HUMORAL IMMUNITY; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; MOUSE; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; SITE DIRECTED MUTAGENESIS; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; GENETICS; HUMAN; IMMUNOLOGY; PROTEIN MOTIF; VACCINATION; VIROLOGY;

JAPANESE ENCEPHALITIS VIRUS; MUS; SUIDAE;

AMINO ACID MOTIFS; ANIMALS; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; GLYCOSYLATION; HUMANS; IMMUNITY, HUMORAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MUTATION; VACCINATION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 79953075516     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-138     Document Type: Article

References (28)

1. Medical significance of togaviruses: an overview of diseases caused by togaviruses in man and in domestic and wild vertebrate animals. RE Shope, The togaviruses New York: Academic Press, Schlesinger RW, 1980 47 82
2. Pathobiology of the flaviviruses. TP Monath, The Togaviridae and Flaviviridae New York: Plenum Press, Schlesinger S, Schlesinger MJ, 1986 375 440
3. Ecologic studies of Japanese encephalitis virus in Japan: VI, Swine infection. WF Scherer J Moyer T Izumi I Gresser J McCown, Am J Trop Med Hyg 1959 8 698 706 14442656
4. Complete nucleotide sequence of and Indian strain of Japanese encephalitis virus: sequence comparison with other strains and phylogenetic analysis. S Vrati RK Giri A Razdan P Malik, Am J Trop Med Hyg 1999 61 677 680 10548310 (Pubitemid 29506356)
5. Flavivirus genome organization, expression and replication. TJ Chambers CS Hahn R Galler CM Rice, Annu Rev Microbiol 1990 44 649 10.1146/annurev.mi.44. 100190.003245 2174669
6. Demonstration of Binding of Dengue Virus Envelope protein to Target Cells. Y Chen T Maguire RM Marks, J. Virol 1996 70 8765 8772 8971005 (Pubitemid 26378460)
7. An External Loop Region of Domain III of Dengue Virus Type 2 Envelope Protein Is Involved in Serotype-Specific Binding to Mosquito but Not Mammalian Cells. JJ Hung MT Hsieng MJ Young CL Kao CC King W Chang, J Virol 2004 78 378 388 10.1128/JVI.78.1.378-388.2004 14671119 (Pubitemid 37549749)
8. Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. E Konishi PW Mason, J. Virol 1993 67 1672 16755 8437237
9. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. SL Allison K Stadler CW Mandl C Kunz FX Heinz, J. Virol 1995 69 5816 5820 7637027
10. -Glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum. MP Courageot MP Frenkiel CD Dos Santos V Deubel P Despres, J. Virol 2000 74 564 572 10.1128/JVI.74.1.564-572.2000 10590151 (Pubitemid 30002943)
11. Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. E Konishi M Yamaoka KS Win I Kurane PW Mason, J Virol 1998 72 4925 4930 9573260 (Pubitemid 28215671)
12. Tracking global patterns of N-linked glycosylation site variation highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Zhang Ming Gaschen Brian Blay Wendy Foley Brian Haigwood Nancy, Glycobiology 2004 14 1229 1246 10.1093/glycob/cwh106 15175256
13. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. A Goffard N Callens B Bartosch C Wychowski FL Cosset C Montpellier, J Virol 2005 79 8400 8409 10.1128/JVI.79.13.8400-8409.2005 15956584 (Pubitemid 40853542)
14. Role of the N-linked glycans of the prM and E envelope proteins in tick-borne encephalitis virus particle secretion. A Goto K Yoshii M Obara T Ueki T Mizutani H Kariwa I Takashima, Vaccine 2005 23 3043 3052 10.1016/j.vaccine. 2004.11.068 15811651 (Pubitemid 40462444)
15. Dengue virus type 2 infects human endothelial cells through binding of the viral envelope glycoprotein to cell surface polypeptides. HY Wei LF Jiang DY Fang HY Guo, J Gen Virol 2003 84 3095 3098 10.1099/vir.0.19308-0 14573814
16. A Single N-Linked Glycosylation Site in the Japanese Encephalitis Virus prM Protein Is Critical for Cell Type-Specific prM Protein Biogenesis, Virus Particle Release, and Pathogenicity in Mice. MK Jeong IY Sang HS Byung SH Youn HL Chan WO Hyun ML Young, J Virol 2008 82 7846 7862 10.1128/JVI.00789-08 18524814
17. Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice. E Konishi N Ajiro C Nukuzuma, Vaccine 2003 21 25-26 3675 3683 10.1016/S0264-410X(03)00382-7 12922097 (Pubitemid 37338192)
18. Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein. R Kaur G Sachdeva S Vrati, J Infect Dis 2002 185 1 12 10.1086/338015 11756975 (Pubitemid 34043010)
19. The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity. SC Wu CH Yu CW Lin IM Chu, Vaccine 2003 21 2516 22 10.1016/S0264-410X(03)00042-2 12744886
20. Flavivirus genome organization, expression, and replication. TJ Chambers CS Hahn R Galler CM Rice, Annual Review of Microbiology 1990 44 649 688 10.1146/annurev.mi.44.100190.003245 2174669
21. Clinical and immunological risk factors for severe disease in Japanese encephalitis. DH Libraty A Nisalak TP Endy S Suntayakorn DW Vaughn BL Innis, Transactions of the Royal Society of Tropical Medicine and Hygiene 2002 96 173 178 10.1016/S0035-9203(02)90294-4 12055808 (Pubitemid 34846562)
22. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine. E Konishi M Yamaoka I Kurane PW Mason, Virology 2000 268 49 55 10.1006/viro.1999.0142 10683326 (Pubitemid 30131970)
23. Japanese encephalitis: virus, infection, and control. A Igarashi, Control of Virus Diseases Marcel Dekker, New York, USA, Kurstak E, second 1992 309 342
24. Nucleic acid immunisation: concepts and techniques associated with third generation vaccines. UA Hasan AM Abai DR Harper BW Wren WJW Morrow, J Immunol Methods 1999 229 1 22 10.1016/S0022-1759(99)00104-0 10556687 (Pubitemid 29505179)
25. Development of a recombinant vaccine against Japanese encephalitis. R Kaur S Vrati, J Neurovirol 2003 9 421 431 12907387 (Pubitemid 36986809)
26. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. S Kodihalli H Goto DL Kobasa S Krauss Y Kawaoka RG Webster, J Virol 1999 73 2094 9971791
27. Induction of HIV-1 envelope (gp120)- specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans. B Doe KS Steimer CM Walker, Eur J Immunol 1994 24 2369 10.1002/eji.1830241017 7523139
28. Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses. Liu Min Xiao-Lian Zhang, Vaccine 2007 25 6572 6580 10.1016/j.vaccine.2007.07.003 17675185